City Therapeutics grants Ron M. Philip 22,649 options

The options vest in full by the earlier of October 15, 2027 or City Therapeutics’ next annual meeting, subject to Ron M. Philip’s continued service.

Rhea-AI Filing Summary

City Therapeutics, Inc. director Ron M. Philip received a direct grant of 22,649 stock options on October 15, 2026, with an exercise price of $18 per share. The options cover 22,649 shares of common stock and vest in full upon the earlier of October 15, 2027 or the company’s next annual meeting of stockholders, subject to his continued service on the vesting date. The options expire October 14, 2036.

Insider Trade Summary

Grant/Award: 22,649 shares

Grant/Award 1 txn

Insider Philip Ron M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	22,649	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 22,649 contracts (Direct)

Footnotes (1)

1. F1. The shares underlying this option vest in full upon the earlier of (i) October 15, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

Key Figures

Stock options granted: 22,649 options Exercise price: $18 per share Underlying common shares: 22,649 shares +2 more

5 metrics

Stock options granted 22,649 options Granted October 15, 2026

Exercise price $18 per share For the granted stock options

Underlying common shares 22,649 shares Shares covered by the options

Options held directly after grant 22,649 options Reported resulting position

Option expiration date October 14, 2036 Expiration date of the granted options

Key Terms

Stock Option (Right to Buy), vest in full, annual meeting of stockholders

3 terms

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

vest in full financial

"vest in full upon the earlier of"

annual meeting of stockholders regulatory

"Issuer's next annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many stock options did CTY director Ron M. Philip receive, and at what exercise price?

Ron M. Philip received 22,649 stock options with an exercise price of $18 per share on October 15, 2026. The options cover 22,649 shares of common stock.

When do Ron M. Philip’s CTY options vest?

The options vest in full upon the earlier of October 15, 2027 or the company’s next annual meeting of stockholders, subject to his continued service on the vesting date.

When do Ron M. Philip’s CTY stock options expire?

The options expire on October 14, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/19/2026 - 05:33 PM EDT Accepted by SEC EDGAR 10/19/2026 - 05:33 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Philip Ron M

(Last) (First) (Middle)

399 BINNEY STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CITY THERAPEUTICS, INC. [ CTY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$18	10/15/2026		A		22,649		(1)	10/14/2036	Common Stock	22,649	$0	22,649	D

Explanation of Responses:

1. The shares underlying this option vest in full upon the earlier of (i) October 15, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.

	/s/ Mary Beth DeLena, as Attorney-in-Fact	10/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)